Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alzheimer Disease (approved 2020)
Alzheimer Disease (Phase 4)
Amyotrophic Lateral Sclerosis (Phase 2)
Atrophy (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Chronic Traumatic Encephalopathy (Phase 2)
Cognition Disorders (Phase 1)
Cognitive Dysfunction (Phase 2)
Corticobasal Degeneration (Phase 1)
Dementia (Phase 2)
Dementia, Vascular (Phase 4)
Depression (Phase 2)
Frontal Lobe (Phase 2)
Frontotemporal Dementia (Phase 4)
HIV (Phase 2)
Lewy Body Disease (Phase 4)
Malformations of Cortical Development (Phase 2)
Neurodegenerative Diseases (Early Phase 1)
Neuroimaging (Phase 4)
Parkinson Disease (Phase 1)
Pick Disease of the Brain (Phase 1)
Supranuclear Palsy, Progressive (Phase 1)
Tauopathies (Phase 2)
Traumatology (Phase 1)
Whole Body Imaging (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue